Cancer drug Treanda, in combination with steroids like prednisone or dexamethasone, could be effective in elapsed and refractory multiple myeloma patients.

The finding was revealed by a recent French analysis and the researchers recommended that Treanda (bendamustine) be considered as a treatment option for patients with advanced multiple myeloma.

Data on side effects was not collected or reported as safety was not part of the analysis.